These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22976832)

  • 1. Treatment of disease recurrence after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a great challenge still to be won.
    Locatelli F; Lucarelli B
    Pediatr Blood Cancer; 2013 Jan; 60(1):1-2. PubMed ID: 22976832
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Inagaki J; Fukano R; Nishikawa T; Nakashima K; Sawa D; Ito N; Okamura J
    Pediatr Blood Cancer; 2013 Jan; 60(1):116-20. PubMed ID: 22847790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile myelomonocytic leukemia.
    Satwani P; Kahn J; Dvorak CC
    Pediatr Clin North Am; 2015 Feb; 62(1):95-106. PubMed ID: 25435114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile myelomonocytic leukemia presenting with features of neonatal hemophagocytic lymphohistiocytosis and cutaneous juvenile xanthogranulomata and successfully treated with allogeneic hemopoietic stem cell transplant.
    Arachchillage DR; Carr TF; Kerr B; Hawkins K; Kelsey A; Judge M; Wynn RF
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):152-5. PubMed ID: 20168243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical non-myeloablative stem cell transplantation as salvage for graft failure in a patient with juvenile myelomonocytic leukemia.
    Perini GF; Kerbauy FR; Fernandes JF; Santos FP; Torres MA; Ribeiro AA; Hamerschlak N
    Pediatr Blood Cancer; 2011 Dec; 57(6):1084. PubMed ID: 21748848
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained responses after clofarabine-based sequential allogeneic stem cell transplantation in children with high-risk, relapse and/or refractory acute myeloid leukemia or juvenile myelomonocytic leukemia: a study on behalf of the French society of bone marrow transplantation or cell therapy (SFGM-TC).
    Grain A; Sirvent A; Strullu M; Françoise M; Mohty M; Guillaume T; Chevallier P; Rialland F
    Leuk Lymphoma; 2016 Dec; 57(12):2937-2941. PubMed ID: 27184944
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.
    Hunger SP; Loh KM; Baker KS; Schultz KR
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
    Manabe A
    Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Graft Failure but Treatment Success: A Case of Reversion to Heterozygosity After Allogeneic Hematopoietic Cell Transplantation With Autologous Hematopoietic Recovery in a Child With CBL-related Juvenile Myelomonocytic Leukemia.
    Oshrine B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e426-e428. PubMed ID: 32032248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
    Elliott MA; Tefferi A; Hogan WJ; Letendre L; Gastineau DA; Ansell SM; Dispenzieri A; Gertz MA; Hayman SR; Inwards DJ; Lacy MQ; Micallef IN; Porrata LF; Litzow MR
    Bone Marrow Transplant; 2006 Jun; 37(11):1003-8. PubMed ID: 16604096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trissomy of chromosome 8 and juvenile myelomonocytic leukemia.
    Valera ET; Brassesco MS; Scrideli CA; Tone LG
    J Pediatr Hematol Oncol; 2012 May; 34(4):e170-1. PubMed ID: 22531497
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
    Koike K; Matsuda K
    Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia.
    Zhao Q; Mahadeo KM; Kapoor N; Abdel-Azim H
    Blood; 2015 Jul; 126(4):561-2. PubMed ID: 26206948
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and treatment of juvenile myelomonocytic leukemia.
    Sakashita K; Matsuda K; Koike K
    Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
    Baron F; Frère P; Fillet G; Beguin Y
    Haematologica; 2001 Sep; 86(9):993-4. PubMed ID: 11532632
    [No Abstract]   [Full Text] [Related]  

  • 16. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Mohamed M; Bierings M; Urban C; Korthof E; Zecca M; Sykora KW; Duffner U; Trebo M; Matthes-Martin S; Sedlacek P; Klingebiel T; Lang P; Führer M; Claviez A; Wössmann W; Pession A; Arvidson J; O'Marcaigh AS; van den Heuvel-Eibrink MM; Starý J; Hasle H; Nöllke P; Locatelli F; Niemeyer CM
    Leukemia; 2007 Mar; 21(3):556-60. PubMed ID: 17268527
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Bader P; Matthes-Martin S; Starý J; Sedlacek P; Duffner U; Klingebiel T; Dilloo D; Holter W; Zintl F; Kremens B; Sykora KW; Urban C; Hasle H; Korthof E; Révész T; Fischer A; Nöllke P; Locatelli F; Niemeyer CM;
    Leukemia; 2005 Jun; 19(6):971-7. PubMed ID: 15800672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung transplantation after hematopoietic stem cell transplantation from the same living donor in a child with juvenile myelomonocytic leukemia and bronchiolitis obliterans.
    Matsuzaki A; Suminoe A; Koga Y; Hara T; Shiraishi T
    Pediatr Blood Cancer; 2008 Oct; 51(4):567. PubMed ID: 18561178
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report.
    Liu C; Fu C; Guo X; Rong L; Li J; Fang Y
    Int J Rheum Dis; 2024 Jan; 27(1):e14882. PubMed ID: 37771000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Ma X; Wu D; Sun A; Qiu H; Fu Z; Wu X; Chen S; Mohty M
    Am J Hematol; 2010 Feb; 85(2):141-2. PubMed ID: 20029991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.